Stock listing
Actuate Therapeutics, Inc.
Selected listing: ACTU · NASDAQ · USD · US
Actuate Therapeutics, Inc. (NASDAQ:ACTU), Health Technology. Latest release Sep 9, 2026: Actuate to Present at the H.C. Wainwright 28th Annual Global…
- Ticker
- NASDAQ:ACTU
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. is a public company traded under the ticker ACTU in the American market. Actuate Therapeutics focuses on developing innovative therapies to address unmet medical needs.
Latest news from Actuate Therapeutics, Inc.
Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma
June 8, 2026
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
May 31, 2026
Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program
May 10, 2026
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
May 6, 2026
Research Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. company profile
View the public company page for Actuate Therapeutics, Inc. on 6ix.
Actuate Therapeutics, Inc. news
Read company news and market updates connected to Actuate Therapeutics, Inc..
Actuate Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Actuate Therapeutics, Inc..